A citation-based method for searching scientific literature

Guobing Li, Shasha Ruan, Xiaolu Zhao, Qi Liu, Yali Dou, Fengbiao Mao. Comput Struct Biotechnol J 2021
Times Cited: 7







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan R Emberson, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Christopher Brightling, Andrew Ustianowski, Einas Elmahi,[...]. N Engl J Med 2021
42

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
John H Stone, Matthew J Frigault, Naomi J Serling-Boyd, Ana D Fernandes, Liam Harvey, Andrea S Foulkes, Nora K Horick, Brian C Healy, Ruta Shah, Ana Maria Bensaci,[...]. N Engl J Med 2020
578
42

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, Kay M Tomashek, Cameron R Wolfe, Varduhi Ghazaryan, Vincent C Marconi, Guillermo M Ruiz-Palacios, Lanny Hsieh, Susan Kline,[...]. N Engl J Med 2021
453
42

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
42

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
28


The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Leon Caly, Julian D Druce, Mike G Catton, David A Jans, Kylie M Wagstaff. Antiviral Res 2020
765
28

The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020.
Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaodong Ren, Lei Tian, Xingke Ju, Han Li, Yongbo Wang, Qianqian Zhao, Hong Liu,[...]. Eur J Med Chem 2020
36
28

COVID-19: Drug Targets and Potential Treatments.
Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria E Campillo,[...]. J Med Chem 2020
124
28

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
28


Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Wesley H Self, Matthew W Semler, Lindsay M Leither, Jonathan D Casey, Derek C Angus, Roy G Brower, Steven Y Chang, Sean P Collins, John C Eppensteiner, Michael R Filbin,[...]. JAMA 2020
153
28

Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
Yan Gao, Liming Yan, Yucen Huang, Fengjiang Liu, Yao Zhao, Lin Cao, Tao Wang, Qianqian Sun, Zhenhua Ming, Lianqi Zhang,[...]. Science 2020
578
28

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.
Sisi Kang, Mei Yang, Zhongsi Hong, Liping Zhang, Zhaoxia Huang, Xiaoxue Chen, Suhua He, Ziliang Zhou, Zhechong Zhou, Qiuyue Chen,[...]. Acta Pharm Sin B 2020
257
28

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, Yuk-Yung Ng, Jenny Lo, Jacky Chan, Anthony Raymond Tam,[...]. Lancet 2020
767
28

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs,[...]. Cell 2020
28

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Timothy P Sheahan, Amy C Sims, Sarah R Leist, Alexandra Schäfer, John Won, Ariane J Brown, Stephanie A Montgomery, Alison Hogg, Darius Babusis, Michael O Clarke,[...]. Nat Commun 2020
828
28

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.
Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, Joseph A Ippolito, Chun-Hui Zhang, Israel Cabeza de Vaca, Maria-Elena Liosi, Karen S Anderson, William L Jorgensen. ACS Med Chem Lett 2020
64
28

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.
Linlin Zhang, Daizong Lin, Yuri Kusov, Yong Nian, Qingjun Ma, Jiang Wang, Albrecht von Brunn, Pieter Leyssen, Kristina Lanko, Johan Neyts,[...]. J Med Chem 2020
206
28

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.
Robert Lorenz Chua, Soeren Lukassen, Saskia Trump, Bianca P Hennig, Daniel Wendisch, Fabian Pott, Olivia Debnath, Loreen Thürmann, Florian Kurth, Maria Theresa Völker,[...]. Nat Biotechnol 2020
338
28

A dynamic COVID-19 immune signature includes associations with poor prognosis.
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, Miguel Muñoz-Ruiz, Duncan R McKenzie, Thomas S Hayday, Isaac Francos-Quijorna,[...]. Nat Med 2020
325
28

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation.
Cecile King, Jonathan Sprent. Trends Immunol 2021
21
28


Remdesivir against COVID-19 and Other Viral Diseases.
Jakob J Malin, Isabelle Suárez, Vanessa Priesner, Gerd Fätkenheuer, Jan Rybniker. Clin Microbiol Rev 2020
53
28

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Dustin Siegel, Hon C Hui, Edward Doerffler, Michael O Clarke, Kwon Chun, Lijun Zhang, Sean Neville, Ernest Carra, Willard Lew, Bruce Ross,[...]. J Med Chem 2017
284
28

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Travis K Warren, Robert Jordan, Michael K Lo, Adrian S Ray, Richard L Mackman, Veronica Soloveva, Dustin Siegel, Michel Perron, Roy Bannister, Hon C Hui,[...]. Nature 2016
715
28

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
28

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
28

Cytokine Storm.
David C Fajgenbaum, Carl H June. N Engl J Med 2020
461
28

Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.
Arun K Ghosh, Margherita Brindisi, Dana Shahabi, Mackenzie E Chapman, Andrew D Mesecar. ChemMedChem 2020
99
14

A structural analysis of M protein in coronavirus assembly and morphology.
Benjamin W Neuman, Gabriella Kiss, Andreas H Kunding, David Bhella, M Fazil Baksh, Stephen Connelly, Ben Droese, Joseph P Klaus, Shinji Makino, Stanley G Sawicki,[...]. J Struct Biol 2011
307
14

Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.
Kevin W Graepel, Xiaotao Lu, James Brett Case, Nicole R Sexton, Everett Clinton Smith, Mark R Denison. mBio 2017
25
14

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
Ludek Eyer, Antoine Nougairède, Marie Uhlířová, Jean-Sélim Driouich, Darina Zouharová, James J Valdés, Jan Haviernik, Ernest A Gould, Erik De Clercq, Xavier de Lamballerie,[...]. J Virol 2019
15
14

Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists.
Dong Yan, Omar Hamed, Taruna Joshi, Mahmoud M Mostafa, Kyla C Jamieson, Radhika Joshi, Robert Newton, Mark A Giembycz. J Pharmacol Exp Ther 2018
10
14

Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
Mohammad Esmadi, Dina Ahmad, Alexander Hewlett. J Gastrointestin Liver Dis 2019
6
16

Drug repurposing approach to fight COVID-19.
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar, Raj Kumar Singh. Pharmacol Rep 2020
95
14

Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, Jerrine Joseph. J Biomol Struct Dyn 2021
148
14

Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages.
Xufang Deng, Matthew Hackbart, Robert C Mettelman, Amornrat O'Brien, Anna M Mielech, Guanghui Yi, C Cheng Kao, Susan C Baker. Proc Natl Acad Sci U S A 2017
145
14



Mechanism of Action of Methotrexate Against Zika Virus.
Sungjun Beck, Zhe Zhu, Michelli F Oliveira, Davey M Smith, Jeremy N Rich, Jean A Bernatchez, Jair L Siqueira-Neto. Viruses 2019
17
14

The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.
Anne-Marie Scola, Matthew Loxham, Steven J Charlton, Peter T Peachell. Br J Pharmacol 2009
20
14


COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.
Semih Baghaki, Can Ege Yalcin, Hayriye Sema Baghaki, Servet Yekta Aydin, Basak Daghan, Ersin Yavuz. Int J Infect Dis 2020
14
14


Baricitinib for COVID-19: a suitable treatment?
Ennio G Favalli, Martina Biggioggero, Gabriella Maioli, Roberto Caporali. Lancet Infect Dis 2020
112
14


Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.
Atala B Jena, Namrata Kanungo, Vinayak Nayak, G B N Chainy, Jagneshwar Dandapat. Sci Rep 2021
27
14


Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection.
Matthijs Raaben, Alexandra W C Einerhand, Lucas J A Taminiau, Michel van Houdt, Janneke Bouma, Rolien H Raatgeep, Hans A Büller, Cornelis A M de Haan, John W A Rossen. Virol J 2007
23
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.